IGF2BP3 and neoplasm: The expression of IGF2BP3 at the mRNA and protein levels was attenuated by knockdown of linc01224, which indicated that downregulation of linc01224 inhibited tumor-promoting activity in HSCC by repressing IGF2BP3 protein synthesis.